[1]蔡锦霞,匡泱漾,徐 艳.低剂量芬吗通联合坤泰胶囊治疗围绝经期综合征的疗效[J].医学信息,2022,35(18):80-82.[doi:10.3969/j.issn.1006-1959.2022.18.020]
　CAI Jin-xia,KUANG Yang-yang,XU Yan.Curative Effect of Low Dose Femoston Combined with Kuntai Capsule on Perimenopausal Syndrome[J].Journal of Medical Information,2022,35(18):80-82.[doi:10.3969/j.issn.1006-1959.2022.18.020]
点击复制

低剂量芬吗通联合坤泰胶囊治疗围绝经期综合征的疗效()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年18期
页码:
80-82
栏目:
论著
出版日期:
2022-09-15

文章信息/Info

Title:
Curative Effect of Low Dose Femoston Combined with Kuntai Capsule on Perimenopausal Syndrome
文章编号:
1006-1959（2022）18-0080-03
作者:
蔡锦霞; 匡泱漾; 徐 艳
（九江市妇幼保健院女性健康管理科，江西 九江 332000）
Author(s):
CAI Jin-xia; KUANG Yang-yang; XU Yan
(Department of Women’s Health Management,Jiujiang Maternal and Child Health Hospital,Jiujiang 332000,Jiangxi,China)
关键词:
围绝经期综合征; 芬吗通; 坤泰胶囊; 性激素
Keywords:
Perimenopausal syndrome; Fenmoton; Kuntai capsules; Sex hormones
分类号:
R588.6
DOI:
10.3969/j.issn.1006-1959.2022.18.020
文献标志码:
A
摘要:
目的 研究低剂量芬吗通联合坤泰胶囊治疗围绝经期综合征的疗效。方法 选取2019年6月-2021年8月我院接受治疗的围绝经期综合征患者60例，按照随机数字表法分为研究组和对照组，每组30例。对照组给予常规剂量芬吗通治疗，研究组给予低剂量芬吗通联合坤泰胶囊治疗，比较两组临床疗效、性激素水平、不良反应发生情况及心理状态。结果 研究组治疗有效率为96.67%，高于对照组的73.33%，差异有统计学意义（P＜0.05）；两组治疗后E2水平高于治疗前，LH、FSH水平低于治疗前，且研究组E2水平高于对照组，LH、FSH水平低于对照组，差异有统计学意义（P＜0.05）；研究组不良反应发生率低于对照组，差异有统计学意义（P＜0.05）；两组治疗后抑郁评分和焦虑评分低于治疗前，但研究组低于对照组，差异有统计学意义（P＜0.05）。结论 低剂量芬吗通联合坤泰胶囊治疗围绝经期综合征的效果良好，有利于改善性激素水平，缓解不良情绪，降低不良反应发生率，具有应用安全性。
Abstract:
Objective To study the efficacy of low-dose femoston combined with Kuntai capsule in the treatment of perimenopausal syndrome.Methods Sixty female patients with perimenopausal syndrome who were treated in our hospital from June 2019 to August 2021 were selected and divided into study group and control group according to the random number table method, with 30 cases in each group. The control group was treated with routine dose of femoston, and the study group was treated with low dose of femoston combined with Kuntai capsule. The clinical efficacy, sex hormone levels, adverse reactions and psychological status were compared between the two groups.Results The effective rate of treatment in the study group was 96.67%, which was higher than 73.33% in the control group, the difference was statistically significant (P<0.05). After treatment, the levels of E2 in the two groups were higher than those before treatment, the levels of LH and FSH were lower than those before treatment, and the levels of E2 in the study group were higher than those in the control group, the levels of LH and FSH were lower than those in the control group, the differences were statistically significant (P<0.05). The incidence of adverse reactions in the study group was lower than that in the control group, and the difference was statistically significant (P<0.05). The depression score and anxiety score of the two groups after treatment were lower than those before treatment, but the study group was lower than the control group, the difference was statistically significant (P<0.05).Conclusion Low-dose femoston combined with kuntai capsule has a good effect in the treatment of perimenopausal syndrome, which is beneficial to improve the level of sex hormones, mood, reducing the incidence of adverse reactions, and has application safety.

参考文献/References:

[1]李书艳,姜文.坤泰胶囊联合芬吗通治疗更年期综合征的疗效及安全性[J].中国妇幼保健,2018,33(5):1100-1102.[2]姜孝好,张辉.芬吗通联合坤泰胶囊对更年期综合征伴失眠患者性激素水平和心理状态的影响[J].中国健康心理学杂志,2018,26(7):972-976.[3]尤俊文.中西医结合治疗围绝经期综合征的临床效果观察[J].宁夏医学杂志,2019,41(11):1014-1017.[4]王忆群,吴锦红,余军辉.更年安胶囊联合戊酸雌二醇片治疗围绝经期综合征临床观察[J].新中医,2017,49(4):84-86.[5]杨文英.芬吗通联合坤泰胶囊对更年期抑郁患者的疗效及对睡眠质量的影响[J].国际精神病学杂志,2019,46(6):1073-1076.[6]项洪艳,金亚蓓,孙占玲.背俞穴埋线对围绝经期抑郁焦虑患者Kupperman评分和HAMA评分的影响[J].上海针灸杂志,2013,32(5):347-348.[7]宋君雅,吴桂荣,蒋漪桦.坤泰胶囊与芬吗通治疗更年期综合征患者的疗效比较[J].实用临床医药杂志,2020,24(15):102-104.[8]钟嘉莉.芬吗通对围绝经期综合征患者FSH激素水平及疗效的影响[J].吉林医学,2020,41(10):2399-2400.[9]李娴彧.坤泰胶囊对更年期综合征伴失眠患者心理状态及睡眠质量影响[J].辽宁中医药大学学报,2020,22(4):162-165.[10]张雪君.芬吗通治疗妇女围绝经期综合征的临床疗效观察[J].中国计划生育学杂志,2015,23(5):330-332.[11]戴雪.芬吗通治疗女性更年期综合征患者的内分泌水平及临床症状改善效果[J].中国妇幼保健,2019,34(8):1803-1805.[12]怀月琴,宋爱清,潘梅钦.芬吗通治疗围绝经期综合征临床疗效观察[J].河北北方学院学报(自然科学版),2019,35(8):38-39.[13]李生强.疏肝解郁法对围绝经期综合征大鼠模型的影响及其分子机制研究[D].福州:福建中医药大学,2015.[14]李晓辉,王庆玖,田梦蝶.坤泰胶囊对围绝经期综合征患者生存质量与卵巢功能影响[J].中国性科学,2021,30(2):119-122.[15]刘伟民.坤泰胶囊联合雌激素替代疗法治疗围绝经期综合征的效果及安全性[J].白求恩医学杂志,2020,18(2):141-143.[16]杨晓艳,汤莹莹,张瑜.坤泰胶囊联合黄体酮胶囊治疗围绝经期综合征的疗效及对患者生活质量的影响[J].中国合理用药探索,2019,16(5):172-175.[17]周春秋.45例坤泰胶囊应用于改善围绝经期症状的疗效观察分析[J].医学理论与实践,2017,30(9):1340-1342.[18]冯兰凤.芬吗通联合坤泰胶囊治疗更年期综合征患者的临床效果[J].慢性病学杂志,2021,22(6):952-955.[19]赵宁,雷勇,刘忠杰,等.低频小剂量雌激素联合坤泰胶囊治疗围绝经期综合征临床疗效观察[J].河北医药,2016,38(19):2989-2990,2991.[20]杨波,徐慧敏,朱亚芹,等.坤泰胶囊联合雌性激素替代疗法治疗更年期综合征的临床效果及可能的作用机制[J].中国性科学,2017,26(11):60-63.

相似文献/References:

[1]张 蕊.六味地黄丸治疗围绝经期综合征的网络药理学研究[J].医学信息,2022,35(09):28.[doi:10.3969/j.issn.1006-1959.2022.09.007]
　ZHANG Rui.Internet Pharmacology Study of Liuwei Dihuang Pills in the Treatment of Perimenopausal Syndrome[J].Journal of Medical Information,2022,35(18):28.[doi:10.3969/j.issn.1006-1959.2022.09.007]
[2]王 伟,张丽萍.于波主任针药结合治疗围绝经期综合征经验撷菁[J].医学信息,2020,33(01):158.[doi:10.3969/j.issn.1006-1959.2020.01.052]
　WANG Wei,ZHANG Li-ping.Director YU BO’s Experience in Acupuncture Combined with Perimenopausal Syndrome[J].Journal of Medical Information,2020,33(18):158.[doi:10.3969/j.issn.1006-1959.2020.01.052]
[3]曾秋萍.坤泰胶囊治疗围绝经期综合征女性的临床疗效及对生活质量的影响[J].医学信息,2021,34(24):160.[doi:10.3969/j.issn.1006-1959.2021.24.042]
　ZENG Qiu-ping.Clinical Efficacy of Kuntai Capsule in the Treatment of Perimenopausal Syndrome Women and its Effect on Quality of Life[J].Journal of Medical Information,2021,34(18):160.[doi:10.3969/j.issn.1006-1959.2021.24.042]

更新日期/Last Update: 1900-01-01